Pneumonia

Pneumonia is a leading cause of death and hospitalization, costing health care systems billions of dollars and an estimated 600,000 adult deaths worldwide each year. Pneumococcal disease is caused by the bacterium Streptococcus pneumoniae and the term describes a group of illnesses, including invasive infections, such as bacteremia/sepsis and meningitis, as well as pneumonia and upper respiratory tract infections. Although all age groups may be affected, the highest rate of pneumococcal disease occurs in young children and older adults. In addition, persons suffering from a wide range of chronic conditions (eg, diabetes, cardiovascular disease) and immune deficiencies are at increased risk.
Viral vs Bacterial Pneumonia

Pneumonia is an infection of one or both lungs which affects alveoli. This article looks at the differences between bacterial and viral pneumonia.

Read More

Overview

Feature Articles

Latest Pneumonia News and Research

Respiratory viruses lacking NS2 protein can be destroyed by the body's immune response

Respiratory viruses lacking NS2 protein can be destroyed by the body's immune response

Research shows fewer deaths related to COVID-19 in Cape Town during fourth wave

Research shows fewer deaths related to COVID-19 in Cape Town during fourth wave

Exploring the relationship between stem cells and COVID-19

Exploring the relationship between stem cells and COVID-19

Specific immunoresponse to SARS-CoV-2 in cats and dogs housed with COVID-19 patients

Specific immunoresponse to SARS-CoV-2 in cats and dogs housed with COVID-19 patients

Plasma SARS-CoV-2 viral RNA as a valuable biomarker for SARS-CoV-2 infection in the lungs

Plasma SARS-CoV-2 viral RNA as a valuable biomarker for SARS-CoV-2 infection in the lungs

Microbial characteristics of COVID-19

Microbial characteristics of COVID-19

Study finds reductions in hospital admissions for childhood infections during first year of pandemic

Study finds reductions in hospital admissions for childhood infections during first year of pandemic

The zoonotic potential of epidemic porcine deltacoronavirus

The zoonotic potential of epidemic porcine deltacoronavirus

COVID-19 symptoms found to vary in different immune contexts

COVID-19 symptoms found to vary in different immune contexts

Comparison of COVID-19 and influenza-associated complications

Comparison of COVID-19 and influenza-associated complications

Study shows probiotics can reduce symptoms of COVID-19 when taken post-exposure

Study shows probiotics can reduce symptoms of COVID-19 when taken post-exposure

SARS-CoV-2 Omicron less pathogenic in hamsters

SARS-CoV-2 Omicron less pathogenic in hamsters

SARS-CoV-2 infection and immunity in pregnancy and fetal development

SARS-CoV-2 infection and immunity in pregnancy and fetal development

Exploring the importance of selenium in COVID-19 patients

Exploring the importance of selenium in COVID-19 patients

Structural blueprint of nanoparticles developed to target neutrophils responsible for acute lung inflammation

Structural blueprint of nanoparticles developed to target neutrophils responsible for acute lung inflammation

New study provides a mutational analysis of SARS-CoV-2

New study provides a mutational analysis of SARS-CoV-2

Pediatric hospital admissions rise with omicron SARS-CoV-2 variant

Pediatric hospital admissions rise with omicron SARS-CoV-2 variant

Exploring the Mediterranean diet as a potential strategy against SARS-CoV-2

Exploring the Mediterranean diet as a potential strategy against SARS-CoV-2

Importance of pneumococcal vaccination during the COVID-19 pandemic

Importance of pneumococcal vaccination during the COVID-19 pandemic

New oral pill for COVID-19 home treatment

New oral pill for COVID-19 home treatment